InspireMD, Inc. — Director's Dealing 2012

Jun 20, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR.OB)
CIK: 0001433607
Period of Report: 2012-06-18

Reporting Person: Weinstein Eyal (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-18	Options to Purchase Common Stock	$0.79	A	50000	Acquired	2022-06-18	Common Stock (50000)	Direct

Footnotes

F1: The option is exercisable in three equal annual installments. The first installment becomes exercisable on June 18, 2013, the second installment becomes exercisable on June 18, 2014 and the third installment becomes exercisable on June 18, 2015, provided that Mr. Weinstein is providing services to the Company or its subsidiaries or affiliates on the applicable vesting date.